Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Characteristics and antioxidant activities of silymarin nanoparticles.

Hsu WC, Ng LT, Wu TH, Lin LT, Yen FL, Lin CC.

J Nanosci Nanotechnol. 2012 Mar;12(3):2022-7.

PMID:
22755015
2.

Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles.

Wu TH, Yen FL, Lin LT, Tsai TR, Lin CC, Cham TM.

Int J Pharm. 2008 Jan 4;346(1-2):160-8. Epub 2007 Jun 28.

PMID:
17689897
3.

Design of acid-responsive polymeric nanoparticles for 7,3',4'-trihydroxyisoflavone topical administration.

Huang PH, Hu SC, Lee CW, Yeh AC, Tseng CH, Yen FL.

Int J Nanomedicine. 2016 Apr 18;11:1615-27. doi: 10.2147/IJN.S100418. eCollection 2016.

4.

Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure.

Yen FL, Wu TH, Lin LT, Cham TM, Lin CC.

Pharm Res. 2009 Apr;26(4):893-902. doi: 10.1007/s11095-008-9791-0. Epub 2008 Nov 25.

PMID:
19034626
5.

Oxidised derivatives of silybin and their antiradical and antioxidant activity.

Gazák R, Svobodová A, Psotová J, Sedmera P, Prikrylová V, Walterová D, Kren V.

Bioorg Med Chem. 2004 Nov 1;12(21):5677-87.

PMID:
15465345
6.

Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.

Parveen R, Baboota S, Ali J, Ahuja A, Vasudev SS, Ahmad S.

Int J Pharm. 2011 Jul 15;413(1-2):245-53. doi: 10.1016/j.ijpharm.2011.04.041. Epub 2011 Apr 22.

PMID:
21549187
7.

A novel solid dispersion system for natural product-loaded medicine: silymarin-loaded solid dispersion with enhanced oral bioavailability and hepatoprotective activity.

Hwang du H, Kim YI, Cho KH, Poudel BK, Choi JY, Kim DW, Shin YJ, Bae ON, Yousaf AM, Yong CS, Kim JO, Choi HG.

J Microencapsul. 2014;31(7):619-26. doi: 10.3109/02652048.2014.911375. Epub 2014 Apr 25.

PMID:
24766208
8.

Curcumin nanoparticles improve the physicochemical properties of curcumin and effectively enhance its antioxidant and antihepatoma activities.

Yen FL, Wu TH, Tzeng CW, Lin LT, Lin CC.

J Agric Food Chem. 2010 Jun 23;58(12):7376-82. doi: 10.1021/jf100135h.

PMID:
20486686
9.

Silymarin-solid dispersions: characterization and influence of preparation methods on dissolution.

Sonali D, Tejal S, Vaishali T, Tejal G.

Acta Pharm. 2010 Dec;60(4):427-43. doi: 10.2478/v10007-010-0038-3.

PMID:
21169135
10.

Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.

Kim MS, Jin SJ, Kim JS, Park HJ, Song HS, Neubert RH, Hwang SJ.

Eur J Pharm Biopharm. 2008 Jun;69(2):454-65. doi: 10.1016/j.ejpb.2008.01.007. Epub 2008 Jan 18.

PMID:
18359211
11.

Extrahepatic biliary obstruction: can silymarin protect liver function?

Hagymási K, Kocsis I, Lugasi A, Fehér J, Blázovics A.

Phytother Res. 2002 Mar;16 Suppl 1:S78-80.

PMID:
11933147
12.

Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs.

Yan-yu X, Yun-mei S, Zhi-peng C, Qi-neng P.

Int J Pharm. 2006 Aug 17;319(1-2):162-8. Epub 2006 Apr 1.

PMID:
16687221
13.

[Development of Silymarin nanocrystals lyophilized power applying nanosuspension technology].

Zhao X, Wang G, Zhang B, Li H, Nie Q, Zang C, Zhao X.

Zhongguo Zhong Yao Za Zhi. 2009 Jun;34(12):1503-8. Chinese.

PMID:
19777833
14.

Formulation, characterization, and in vitro evaluation of silymarin-loaded lipid microspheres.

Abrol S, Trehan A, Katare OP.

Drug Deliv. 2004 May-Jun;11(3):185-91.

PMID:
15204637
15.

Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats.

Ramakrishnan G, Raghavendran HR, Vinodhkumar R, Devaki T.

Chem Biol Interact. 2006 Jun 10;161(2):104-14. Epub 2006 Mar 22.

PMID:
16643877
16.

Silymarin nanoparticle prevents paracetamol-induced hepatotoxicity.

Das S, Roy P, Auddy RG, Mukherjee A.

Int J Nanomedicine. 2011;6:1291-301. doi: 10.2147/IJN.S15160. Epub 2011 Jun 22.

17.

In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery.

Wang Y, Zhang D, Liu Z, Liu G, Duan C, Jia L, Feng F, Zhang X, Shi Y, Zhang Q.

Nanotechnology. 2010 Apr 16;21(15):155104. doi: 10.1088/0957-4484/21/15/155104. Epub 2010 Mar 23.

PMID:
20332565
18.

Silymarin protection against major reactive oxygen species released by environmental toxins: exogenous H2O2 exposure in erythrocytes.

Kiruthiga PV, Shafreen RB, Pandian SK, Devi KP.

Basic Clin Pharmacol Toxicol. 2007 Jun;100(6):414-9.

19.

A novel strategy to produce highly stable and transparent aqueous 'nanosolutions' of water-insoluble drug molecules.

Wang JX, Zhang ZB, Le Y, Zhao H, Chen JF.

Nanotechnology. 2011 Jul 29;22(30):305101. doi: 10.1088/0957-4484/22/30/305101. Epub 2011 Jun 27.

PMID:
21705830
20.

Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system.

Wu W, Wang Y, Que L.

Eur J Pharm Biopharm. 2006 Jul;63(3):288-94. Epub 2006 Mar 9.

PMID:
16527467

Supplemental Content

Support Center